Brief: Perspective Therapeutics, PharmaLogic Announce Collaboration For Development, Production Of Theranostics For Cancer Care
14/03/2023 12:25
March 14 (Reuters) - Perspective Therapeutics Inc
CATX.A :
* PERSPECTIVE THERAPEUTICS AND PHARMALOGIC ANNOUNCE
COLLABORATION
FOR DEVELOPMENT AND PRODUCTION OF THERANOSTICS FOR CANCER CARE
* PHARMALOGIC HOLDINGS - UNDER DEAL, PHARMALOGIC WILL
PRODUCE &
SUPPLY DOSES OF VMT-01 & VMT-Α-NET FOR USE IN PERSPECTIVE'S
EARLY-STAGE CLINICAL TRIALS
Source text for Eikon: ID:nPnbPtNfpa
Further company coverage: CATX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Perspective Therapeutics
See all newsPerspective Therapeutics Q2 net loss widens on higher R&D costs
Brief: Perspective Therapeutics Q2 EPS USD -0.22
Brief: Perspective Therapeutics Expands Therapeutic Focus Areas First Patient Dosed With Vmt-Α-Net In The Meningioma Cohort Of A Phase 1/2A Study
Brief: Perspective Therapeutics Q1 EPS USD -0.25
Perspective Therapeutics rises as experimental cancer drug shows promise